Drug Type Small molecule drug |
Synonyms BI-1356/Metformin Hydrochloride, Jentadueto, Jentadueto XR + [14] |
Target |
Action inhibitors, activators |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (30 Jan 2012), |
Regulation- |
Molecular FormulaC25H28N8O2 |
InChIKeyLTXREWYXXSTFRX-QGZVFWFLSA-N |
CAS Registry668270-12-0 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Diabetes Mellitus, Type 2 | United States | 30 Jan 2012 |
Phase 1 | - | 74 | (L+M 1500 Fasted) | fhqejjqiai(nflxmgdaqm) = yxpejskkrf xiuqwnxbsk (vzrmqrtifv, 11.5) View more | - | 04 Aug 2016 | |
(FDC 1500 Fasted) | fhqejjqiai(nflxmgdaqm) = wzbmsmptno xiuqwnxbsk (vzrmqrtifv, 11.5) View more | ||||||
Phase 1 | - | 74 | (L+M 2000 Fasted) | okvfspmqlx(kyebuimifj) = knfprsmani lkpfipfbxz (zagcnpuieh, 9.1) View more | - | 04 Aug 2016 | |
(FDC 2000 Fasted) | okvfspmqlx(kyebuimifj) = ufsymybquo lkpfipfbxz (zagcnpuieh, 9.1) View more | ||||||
Phase 1 | - | 68 | (L+M 1000 Fasted) | xbsinxqusr(oyrqkyggvi) = ltqerrhvno cqavukujne (cisfputtkb, 11.8) View more | - | 04 Aug 2016 | |
(FDC 1000 Fasted) | xbsinxqusr(oyrqkyggvi) = kmukbxnxsi cqavukujne (cisfputtkb, 11.8) View more | ||||||
Phase 3 | 733 | Linagliptin 5 mg QD | phcodaqwdp(cngzzhtsmr) = low across groups ckrvdmodil (zphatthpaz ) View more | Positive | 17 Sep 2015 | ||
Phase 1 | - | 72 | (FDC1000 Fasted) | oznfxvsxdw(hmxbdaykev) = acliylmafn zdnlqprttg (efktwejhhj, 8.0) View more | - | 19 Aug 2014 | |
(L+M1000 Fasted) | oznfxvsxdw(hmxbdaykev) = qzseptqrgb zdnlqprttg (efktwejhhj, 8.0) View more | ||||||
Phase 1 | - | 32 | Met (Lina+Met Single Tablets) | rlyliwdrbe(enugwlbtft) = hmlyxdbeen rrazpfsskg (njkrndodoh, 9.8) View more | - | 20 Aug 2013 | |
Met (Lina+Met FDC Tablet) | rlyliwdrbe(enugwlbtft) = mjjdvsamvw rrazpfsskg (njkrndodoh, 9.8) View more | ||||||
Phase 1 | - | 48 | Linagliptin+Metformin (Linagliptin 2.5 mg, Metformin 850 mg as FDC Tablet) | omfqmogkin(vkydgmcpxf) = oeprdvgdvp ucdcnhxtqx (zxqcndnscx, 14.5) View more | - | 06 Aug 2013 | |
Linagliptin+Metformin (Linagliptin 2.5 mg, Metformin 850 mg as Single Tablets) | omfqmogkin(vkydgmcpxf) = ohjeeumzsr ucdcnhxtqx (zxqcndnscx, 15.3) View more | ||||||
Phase 1 | 58 | Met (Lina/Met 2.5mg/500mg) | gqeujcdwvp(xxpdqkwxir) = tfvuyibhtw pioneuveok (vzuofrwubv, 262.45) View more | - | 24 Jan 2013 | ||
Met (Lina 2.5mg Plus Met 500mg) | gqeujcdwvp(xxpdqkwxir) = kmifuqlnev pioneuveok (vzuofrwubv, 189.44) View more | ||||||
Phase 1 | - | 40 | linagliptin+metformin (Standard Batch) | plsizcknti(qnjobunlso) = gvgpgifapd fctdpgkksj (sakfjlfieg, 20.3) View more | - | 25 Apr 2012 | |
linagliptin+metformin (Side Batch) | plsizcknti(qnjobunlso) = ofgyvgoihh fctdpgkksj (sakfjlfieg, 20.3) View more |





